Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer
about
HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cellsHigh-risk human papillomavirus targets crossroads in immune signalingSingle nucleotide polymorphisms in DNA repair genes and risk of cervical cancer: A case-control studySingle nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancerGenetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: a population-based case-control study.In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response.Common genetic variants and risk for HPV persistence and progression to cervical cancer.Anti-Müllerian hormone deficiency in females with Fanconi anemia.Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer.Meta-analysis of XRCC1 polymorphism and risk of female reproductive system cancerDevelopment of a PCR assay to detect papillomavirus infection in the snow leopard.Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohortTNF-alpha rs1800629 polymorphism is not associated with HPV infection or cervical cancer in the Chinese population.Genomic instability and cancer: lessons learned from human papillomaviruses.Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection.From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice.Tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical lesions: a meta-analysisAssociation between tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical cancer.Hypersensitivity to chemoradiation in FANCA carrier with cervical carcinoma-A case report and review of the literature.Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.The fanconi anemia pathway limits human papillomavirus replicationGenetic polymorphisms of FAS and EVER genes in a Greek population and their susceptibility to cervical cancer: a case control study.Prevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping testAssociation between three exonuclease 1 polymorphisms and cancer risks: a meta-analysis.Genetic susceptibility of cervical cancer.The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.The CYBA Gene (⁎)49A>G Polymorphism (rs7195830) Is Associated with Hypertension in Patients with Coronary Artery Disease.Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer.Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents.Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins.Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis.Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy.Association of human papillomavirus with Fanconi anemia promotes carcinogenesis in Fanconi anemia patients.Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.Genetic susceptibility in cervical cancer: From bench to bedside.XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk.
P2860
Q21559659-E0E1E048-A275-45E1-9F05-9DDB37A3DD3FQ28084802-132C1C31-9E9F-4690-BC9D-4F3B84AFDE3AQ28384976-EB6C601D-9026-418C-B27A-94D64401A1A9Q28730698-BD854717-840A-4185-A0DA-0931D5C9DC4FQ30541935-A8C630CE-8ED0-4BDE-9B87-7353285AE499Q30562561-8DF8609A-9D66-4C44-B329-94FF2615D664Q30661799-6682E692-9FBA-4E68-B6A1-84E3C8244589Q33525051-2482FB23-2CB3-40DB-997E-540BBD54C46BQ33569005-5A5FEFDA-312A-48A5-A6A2-64E59D67CB87Q33618495-E9FE904E-1A7B-4D01-AB2F-94A7E5B65475Q33709735-9303F955-B351-4399-95CA-D0B19AE7FE4DQ33964484-A86D8CD2-EEF1-47C7-A139-791E051A7E15Q34366883-822B70D0-78DD-4B10-9313-79C870EF34AFQ34428473-DE6600B5-0CC7-41FA-BC02-E2EEFAA8D79CQ34612265-A4196AB4-8354-4CBE-89E7-49849CF43B1DQ34714582-2BC7A521-8DD2-41E8-B11A-57E17BB4F1DBQ34774870-40942296-0331-4AFF-B3AD-6F25D5024DB4Q34981240-03003727-386C-4F3F-B72B-A31916A4F13EQ35479972-12A5F345-68E2-4F9A-8E4B-E3CE967E9821Q35768837-E9B1D065-106E-4BF6-8FCD-2F1964BDD403Q35796047-14330D5E-5E86-45DB-A73A-D3388FDB1CF3Q36171920-58454A0F-E72B-4897-A246-2712E9316DBBQ36207032-381B0D0F-0D8F-4178-97CF-A85F54E9F972Q36587825-217A9C60-96A6-41F0-A807-1BB5835AECE4Q36627508-C27731C4-B178-49B1-B5DA-5BCD07378EE1Q36683202-76F628FF-C3D4-41B7-A943-9033D1636B96Q36867985-F78BCF8D-C819-483B-BB11-E52F1E309EDDQ36974052-7FA533D0-FE5C-4A2D-B8D9-CC3D2312C4E5Q37318746-C671802B-6159-466B-B9B7-7CC5A4A15EA5Q37347357-DA20BCD1-E41F-45AF-AF44-5851EC08B6FEQ37661158-26EEF79A-4E25-49AA-9D07-9AF2892F35C0Q37709256-D6DC5162-C83D-44F6-B455-FB91BE2C5B31Q37722678-511AC96F-DA3A-4DA9-A477-AD8A5E7633F2Q37889149-8133F428-2F03-4CC3-95D5-CC266EA3B0EAQ38036688-A33672DF-8931-4E40-80DE-0FB5DA75BCB1Q38380216-2FE8184C-D4ED-4108-97B1-B1C0838652CFQ38642781-60095339-E223-46EA-AD98-0127573233EEQ38955593-A76DCF3C-8242-404F-A655-294344BAC43EQ39329199-CCCD75DA-633F-4435-892C-C24A892BC3B0Q39443419-1379BB60-273D-4433-90C6-6955ADD68A3B
P2860
Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Common variants in immune and ...... progression to cervical cancer
@en
type
label
Common variants in immune and ...... progression to cervical cancer
@en
prefLabel
Common variants in immune and ...... progression to cervical cancer
@en
P2093
P2860
P50
P356
P1476
Common variants in immune and ...... progression to cervical cancer
@en
P2093
Carolina Porras
M Concepcion Bratti
Mark E Sherman
Paula González
Robert D Burk
Rolando Herrero
Sophia S Wang
Z Elizabeth Lan
P2860
P356
10.1086/595563
P407
P577
2009-01-01T00:00:00Z